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Strengths and limitations of this study
 ► To estimate the effects of access to primary care on 
the consumption of antibiotics, we use geographi-
cal and time variation in unfilled general practices 
in Hungary.
 ► Our results are based on administrative records of 
antibiotic use of the entire population of Hungary liv-
ing in villages between years 2010 to 2015.
 ► We analyse the quantity and quality of antibiotic 
consumption, by separating the narrow-spectrum 
versus broad-spectrum as well as the Access versus 
Watch-Reserve antibiotic prescriptions according to 
the AWaRe classification.
 ► The external validity of the findings is restricted to 
healthcare systems with mostly single-handed gen-
eral practices, which serve as the first point of con-
tact to the system.
AbStrACt
Objective We analyse the effect of primary care 
availability on antibiotic consumption and on the quality of 
antibiotic prescribing behaviour.
Design Retrospective panel design, secondary analysis 
of settlement-level administrative panel data (n=2320 
settlements, T=72 months).
Participants and setting We analyse antibiotic 
consumption of the population of villages in Hungary, 
over years 2010 to 2015. We exploit the geographical and 
time variation in unfilled (mainly single-handed) general 
practices as a source of exogenous variation in the 
availability of primary care. We control for socioeconomic 
characteristics and settlement fixed effects in a panel 
regression framework.
Outcome measures Antibiotic expenditures and days 
of therapy (DOT); consumption of narrow-spectrum and 
broad-spectrum antibiotics; consumption of Access, 
Watch and Reserve antibiotics according to the AWaRe 
categorisation; number of visits to the general practitioner 
(GP).
results If the general practice of a village becomes 
unfilled, the number of GP visits decreases on average 
by 9.3% (95% CI 5.6% to 12.9%), antibiotics DOT 
decrease on average by 3.2% (95% CI 1.0% to 5.4%) 
and expenditures on antibiotics decrease on average 
by 2.5% (95% CI 0.3% to 4.7%). The negative effect on 
antibiotic consumption is stronger in settlements where 
secondary care is less available, and where antibiotics 
were previously overprescribed. The quality of prescribing 
behaviour measured by the relative changes in the 
narrow-spectrum vs broad-spectrum as well as the 
Access versus Watch and Reserve antibiotics deteriorates 
significantly as a consequence of worse primary care 
availability.
Conclusions Limited availability of primary care reduces 
the consumption of antibiotics and at the same time 
impairs the quality of prescriptions through a decrease of 
the number of doctor-patient encounters.
IntrODuCtIOn
‘Antibiotic resistance is one of the most signif-
icant threats to patients’ safety in Europe. 
It is driven by overusing antibiotics and 
prescribing them inappropriately.’1 Global 
consumption of antibiotic drugs increased 
by 35% between 2000 and 2010.2 Antibiotics 
can be life-saving, however, overuse of them 
can increase the susceptibility to infections 
and disease.3 The WHO identifies antimicro-
bial resistance as one of the top 10 threats to 
global health in 2019.4
We analyse the effect of primary care avail-
ability on antibiotic consumption and on the 
quality of antibiotic prescribing behaviour. 
In European countries, with the exception 
of Turkey, the average age of general prac-
titioners (GPs) is between 45 and 55 years5 
so lack of supply in primary care is either 
already a problem, or will be a problem in 
the near future, in many places. For instance, 
in Britain, around 10% of GP positions were 
unfilled in 2015, and the situation is wors-
ening daily.6
Little is known about the relationship 
between primary care availability and antibi-
otic consumption. Limited access to primary 
care is likely to lead to fewer consultations, 
hence lower access to prescriptions. However, 
it can also have opposite effects since if GPs 
spend more time with their patients then the 
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prescription of antibiotics can be reduced.7 Results from 
Switzerland and also from 17 European countries show 
that the density of physicians is positively related to outpa-
tient antibiotic consumption.8 9 Based on regional data 
from Hungary, a previous study did not find evidence for 
a relationship between antibiotic use and the density of 
pharmacies or the number of enrolled patients per GP.10 
In this paper, we use more detailed longitudinal adminis-
trative data from a later period from Hungary and exploit 
the process of general practices becoming unfilled as a 
natural experiment to analyse the question and reach 
different conclusions.
Institutional background in Hungary
The following summary of primary care in Hungary is based 
on Gaál et al, 2011, Wilm et al, 2015.11 12 In Hungary, the 
municipalities are responsible for the provision of primary 
care. The majority of primary care services are provided 
by general practitioners (family physicians or family paedi-
atricians). Local governments designate primary care 
districts to the GPs, who are not allowed to refuse patients 
from their district. On the other hand, patients have the 
right to choose their GP. The overwhelming majority of 
GPs work in single-handed practices, group practices are 
very rare.12 To work in a primary care district with a terri-
torial supply obligation, family doctors must purchase 
a licence. Thus practices can be bought and sold, while 
local governments still keep a control over who serves as a 
GP. GP care is provided for free, and at least in principle, 
GPs act as gatekeepers. However, several specialist care 
services can be accessed without the referral of a GP (eg, 
dermatology, ear, nose and throat diseases, gynaecology, 
traumatology). GPs’ financing is mostly based on capita-
tion, with some supplements depending for example on 
the age composition of the patients and the type of settle-
ments covered. In 2015, there were 6277 practising GPs 
in Hungary, the average number of patients per GP was 
1566. Meanwhile, there are 3155 settlements in Hungary, 
and the total population is 9.8 million.13
A severe problem of the Hungarian primary care system 
is that around 5% of the – overwhelmingly single-handed 
– GP practices are unfilled. The high ratio of unfilled GP 
positions in Hungary is despite the fact that the govern-
ment offers financial subsidies if a GP takes up a practice 
that has been unfilled for at least 6 months. The unfilled 
practices are mostly located in remote, less developed 
areas of the country. If a practice becomes unfilled it will 
be partly covered by the GPs of neighbouring primary 
care districts. Hence, on the one hand, deputy GPs in the 
remote areas have to travel a lot, so as to provide some 
care at the unfilled practices. On the other hand, patients 
in unfilled districts cannot access a GP locally every day of 
the week. If they need to see a GP when the deputy GP is 
not around, they have to travel to another district (typi-
cally to another settlement).
Consumption of antibiotics in Hungary
Hungary had the ninth lowest per capita consumption 
of antibiotics for systemic use out of 30 European Union 
(EU)/European Economic Area (EEA) countries in 2016 
(the defined daily dose (DDD) per 1000 inhabitant-days 
was 15.4 in Hungary, 21.9 in the EU/EEA).14 However, 
quality indicators of antibiotic prescribing behaviour 
do not show such a bright picture. For instance Juhasz 
et al,15 report some inappropriateness of antibiotic treat-
ment in acute cystitis and Marton et al16 already showed 
alarming evidence of high incidence of antibiotic resis-
tance in Hungary almost three decades ago. Regarding 
the quality indicators in international comparison, the 
ratio of broad-spectrum to narrow-spectrum antibotics in 
community consumption is the second largest in the EU/
EEA17 (Broad-spectrum antibiotics are known to have a 
high potential to cause antimicrobial resistance.18 19). Out 
of 12 quality indicators such as the seasonal variation of 
antibiotic prescriptions or the use of certain broad-spec-
trum antibiotics, Hungary is in the worst quartile of EU/
EEA countries in five cases, in the second worst quartile 
in four cases and in the better half in only three cases.20
Furthermore, the recent WHO Essential Medicines 
List21 classifies antibiotics into Access, Watch, Reserve 
and Other categories to ensure appropriate prescribing 
behaviour (AWaRe classification). In Hungary, compared 
with the median value in the European region, a smaller 
share of antibiotic consumption belongs to the Access 
group (48% vs 56%) and a larger share to the Watch 
group (38% vs 29%) as well as to the Reserve group (0.5% 
vs 0.2%), putting the country into the worst quartile in 
terms of these quality measures as well.18 Responding 
to these results, the prescription rate of antibiotics has 
become part of the primary care performance indicator 
system in Hungary since 2011.22
MetHODS
Data
We combine three data sources to create settlement-level 
monthly administrative panel data (n=2320 settlements, 
T=72 months over years 2010 to 2015).
General practices
We obtained the list of filled and unfilled general practices 
from the National Health Insurance Fund Administration 
(NHIFA) for the time between 2004 to 2017. (These data 
were provided to us by the NHIFA free of charge in the 
framework of secondary use of public data.) We know the 
zip code of the site of the practice, the list of settlements 
the practice caters for and the start and end date (month) 
of the practice having been unfilled. In those settlements 
where there is only one general practice, we exactly know 
whether it is unfilled or not in a given month. However, 
our information is less precise in settlements (mainly 
towns and cities) where more than one general practice 
is available. We know if some of them are unfilled, but 
cannot identify the exact part of the settlement that is 
not covered by GP care. To alleviate the consequences 
of this data limitation, we focus our analysis on villages, 
of which 77% are covered by only one general practice. 
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Meanwhile, the lack of GP care availability is typically an 
issue in villages: although only 30% of the population live 
there, 81% of unfilled general practices are located there.
Our main explanatory variable on the settlement level 
is the ratio of the unfilled practices relative to the total 
number of practices (filled plus unfilled) covering the 
given settlement. If a village is covered by one unfilled 
practice then the ratio of unfilled practices equals one 
there. (Most of the villages (72.5%) are covered by prac-
tices that cater for adults and children as well; 18.3% of 
the practices covering villages cater for adults only and 
9.2% for children only).
Settlement-level demographic, socioeconomic and GP care data
We also use the T-STAR municipal statistical system of the 
Central Statistical Office of Hungary. This contains wide-
range annual settlement-level demographic data (such as 
the gender and age composition of the population) and 
socioeconomic data (such as the unemployment rate).
Furthermore, the database contains, by settlement, 
the annual number of visits to all GPs based in the given 
settlement. Thus if a general practice caters for several 
settlements then all the visits are attached to the basis 
settlement. Due to this limitation, we take the following 
steps to generate the database of the number of GP visits. 
First, using the register of general practices, for each 
settlement we identify the settlement that provides the 
GP care (this is important for small villages, which do 
not host a health centre). Second, we calculate the popu-
lation of the catchment area of the general practices of 
a given settlement, using the population statistics from 
T-STAR. Finally, we divide the number of GP visits with 
the estimated population to construct the per capita indi-
cator on the catchment area level.
Consumption of antibiotics
Data on the use of antibiotics, covering the entire popu-
lation of Hungary, come from the National Healthcare 
Services Centre (NHSC) through an agreement between 
the NHSC and the Institute of Economics, Centre for 
Economic and Regional Studies of the Hungarian 
Academy of Sciences. They contain information on phar-
maceuticals in the Anatomical Therapeutic Chemical 
(ATC) group ‘J01’ (antibiotics with systemic use) that 
were purchased through pharmacies, hence only relate 
to the ambulatory setting and exclude hospital care. Only 
prescription drugs are recorded (over-the-counter sales 
are excluded) but this is not a limitation because of the 
prescription-only status of antibiotics in Hungary (Some 
non-prescription sales do occur but they constitute only 
around 2% of all sales.23). Our data cover prescriptions 
both in primary care and specialist outpatient care, hence 
we measure the overall effect on the use of antibiotics.
The NHSC data set covers years 2010 to 2015. It provides 
information on the name, identifier code and detailed 
ATC code of the antibiotic medication, the date of the 
purchase, the amount purchased and the associated 
expenditure (the sum of social security and out-of-pocket 
payments). It also includes the zip code of the patient’s 
address, the patient’s year of birth and gender and the 
International Statistical Classification of Diseases code of 
the diagnosis for which the prescription was given. Using 
the zip codes, we construct monthly indicators of anti-
biotic use (days of therapy (DOT) and expenditure of 
all antibiotics as well as of various subcategories) on the 
settlement level.
We define various subcategories so as to analyse 
the quality of antibiotic prescription. First, following 
Cormican et al,17 we distinguish the consumption of 
narrow-spectrum penicillins, cephalosporins, macro-
lides (ATC codes J01(CA+CE+CF+DB+FA01)) and of 
broad-spectrum penicillins, cephalosporins, macrolides 
and fluoroquinolones (J01(CR+DC+DD+(F-FA01)+MA)). 
Then, we define a quality index as the ratio of the 
consumption of the narrow-spectrum and the broad-spec-
trum categories. (This is the reciprocal of the index used 
by Juhasz et al.15 Since there are a lot of zero values in 
the consumption of narrow-spectrum antibiotics on the 
settlement-month level, the original index is not defined 
in many cases, hence we use its reciprocal). To lower the 
risk of antibiotic resistance, a higher value of this quality 
indicator is desirable.
Second, we use the AWaRe (Access – Watch – Reserve) 
classification of the list of essential medicines21 to assess 
the quality of consumption. The Access category includes 
first and second choice antibiotics that should be widely 
available in healthcare settings, while antibiotics in the 
Watch and Reserve categories have a higher potential for 
resistance to develop and their use as first and second 
choice treatment should be limited.18 Since the Reserve 
category comprises only a small fraction (0.5%) of antibi-
otic consumption in Hungary, we analyse the consump-
tion of Watch and Reserve categories jointly.
Finally, to generate descriptive statistics and to relate 
the consumption of antibiotics to total pharmaceutical 
consumption, we also use publicly available county-level 
statistics on pharmaceutical sales from the NHIFA. 
(Since they come from the same administrative sources, 
the NHSC and NHIFA antibiotic consumption data are 
very similar both in their levels and in their county-level 
variation (the correlation is above 0.95)).24 Similarly to 
the NHSC data above, only prescribed pharmaceutical 
purchases in public pharmacies are included in these 
statistics.
Statistical analysis
Regressions for the quantity and quality of antibiotic consumption
In our baseline analysis, we estimate the effect of unfilled 
general practices on antibiotic consumption using the 
settlement-month panel of antibiotic DOT and expendi-
tures, which was created from the NHSC data. We restrict 
the analysis to villages and estimate the following panel 
model:
 antibioticss,t = γ0 + γuunfilleds,t + γdDt
date + γhhs,t + νs + εs,t  
 (1)
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Table 1 Average antibiotic days of therapy per 1000 
inhabitant-days by gender and age
 
 
Age 
group
Males Females
Mean SE Median Mean SE Median
0–5 18.43 0.03 16.64 17.10 0.03 15.18
6–17 17.25 0.03 14.75 17.79 0.03 15.50
18–39 10.41 0.01 9.78 15.39 0.02 14.85
40–59 9.12 0.01 8.75 13.83 0.02 13.47
60– 13.91 0.02 13.35 13.54 0.02 13.19
Total 11.97 0.01 10.68 14.77 0.01 14.03
Statistics weighted by the size of each settlement-gender-age 
group. SE is the standard error of the mean. NHSC data, years 
2010 to 2015.
where s indicates settlements and t the time measured 
in months. In various model specifications the outcome 
variables (antibioticss,t) are the level and logarithm of 
antibiotic DOT per 1000 inhabitant-days as well as the 
logarithm of social security expenditures per 1000 inhab-
itants. (The monthly settlement-level DOT or expendi-
tures are zero only for a tiny fraction of observations, 
hence the logarithms are missing only in very few cases). 
Also, as quality indicators, we examine the DOT of the 
subcategories (narrow-spectrum, broad-spectrum, Access 
and Watch-Reserve) as well as the quality index (ratio 
of narrow-spectrum and broad-spectrum antibiotics) 
defined above.
Our main explanatory variable is the ratio of unfilled 
general practices among all practices covering settle-
ment s in month t (unfilleds,t). Further explanatory vari-
ables include time fixed effects (Dt
date) to control for 
time trends and various settlement-level indicators (hs,t) 
from the T-STAR database to control for health needs 
and healthcare supply. In particular, we proxy health 
needs, that is, the demand-side determinants of antibiotic 
consumption, with the age-gender distribution and the 
socioeconomic characteristics of the settlement (ratio of 
females, ratio of residents aged 0 to 17 years and aged 60+ 
years, local unemployment rate, prescription exemption 
rate). According to table 1, the use of antibiotics differs 
by gender and age, hence the age-gender distribution can 
partly capture the settlement-specific demand for anti-
biotics. Socioeconomic characteristics are expected to 
affect the demand via income and health effects. Finally, 
we measure the supply of healthcare beyond primary 
care with the local (micro-regional) specialist outpatient 
capacities (annual specialist outpatient hours per 1000 
inhabitants).
We also include settlement-level fixed effects in equa-
tion (1), (vs), which capture all time-invariant charac-
teristics of the settlements (such as region, distance to 
the nearest town or location of the GP practice). Hence 
this estimation method yields unbiased estimates for 
the parameters even if we allow that settlements with 
unfilled and filled practices may systematically differ 
from each other across time-invariant dimensions that we 
cannot measure (Wooldridge, 2010; section Fixed Effects 
Methods).25 In other words, the inclusion of settlement 
fixed effects allows us to identify the impact of primary 
care availability on antibiotic consumption from the with-
in-settlement time variation of filled/unfilled status, not 
just from the cross-sectional geographical variation.
The dependent variables in equation (1) are calculated 
on per capita basis and hence the models are inherently 
heteroscedastic, with larger variances observed in smaller 
settlements (as also shown in online supplementary figure 
A1 in appendix A1). Hence we estimate the equation with 
weighted fixed effects least squares, using the (time-aver-
aged) population of the settlements as weights. According 
to online supplementary figure A2 in appendix A1, the 
weighted residuals are much closer to homoscedasticity. 
We cluster SEs on the micro-regional level to take into 
account potential interdependencies of shocks in the 
local healthcare systems (in line with Cameron et al26; the 
clustering formula is provided by Cameron and Trivedi, 
200927 (section Cluster-robust standard errors)).
For the sake of comparison, we re-estimate equation 
(1) with a random effects specification for vs as well. 
This specification assumes that the settlement-level 
time-invariant unobserved factors are uncorrelated with 
the explanatory variables(Wooldridge, 2010;25 section 
Random Effects Methods). We choose between the fixed 
effects and the random effects specifications with a Haus-
man-type test (Wooldridge, 2010;25 section The Hausman 
Test Comparing the RE and FE Estimators), imple-
mented with the xtoverid function28 of the Stata statistical 
software.29 All other calculations are performed in Stata 
as well.
Heterogeneity analyses
We also investigate effect heterogeneities. First, we 
extend equation (1) and interact the ratio of unfilled 
general practices (unfilleds,t) with the micro-regional 
specialist outpatient hours per 1000 inhabitants (popu-
lation-weighted mean=1.22, SD=0.80), with the binary 
indicator of the presence of a pharmacy in the settlement 
(weighted proportion=0.775) and, to capture the socio-
economic conditions, with settlement-level unemploy-
ment rate (weighted mean=0.105, SD=0.071) and with 
the prescription exemption rate (weighted mean=0.039, 
SD=0.025).
Second, we analyse effect heterogeneities according to 
the initial consumption level of antibiotics. Our aim is to 
understand if the negative estimated effect of unfilled 
practices originates from settlements where the use of 
antibiotics was relatively high, conditional on health 
needs and healthcare supply. To do so, first we estimate a 
cross-sectional regression of the annual antibiotic use in 
year 2010, and generate the residuals:
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Figure 1 Spatial distribution of settlements with unfilled 
general practices, December 2015 (data source: National 
Health Insurance Fund Administration).
 antibioticss,2010 = γ0
2010 + γu2010unfilleds,2010 + γh
2010hs,2010 + εs,2010 
 (2)
The outcome variable in equation (2) is the logarithm 
of the annual antibiotic DOT in 2010, and settlement-level 
controls (hs) are the same as in equation (1). The gener-
ated residuals have a SD of 0.35 (with zero mean). Then, 
we re-estimate equation (1), with adding the interaction 
term between the ratio of unfilled general practices and 
the year 2010 residual of equation (2). Here we use data 
for years 2013 to 2015, so that we can interpret the inter-
action term as the heterogenous effect according to the 
baseline use of antibiotics.
Regressions for GP care use
Finally, to investigate the mechanisms of how primary 
care availability affects the use of antibiotics, we estimate 
the impact of the ratio of unfilled general practices on the 
annual number of GP visits, and on antibiotic prescrip-
tions per GP visit. We use the settlement-level (more 
precisely, GP catchment area level) GP care use statistics 
as described in section Settlement-level demographic, 
socio-economic and GP care data and restrict the analysis 
to villages. We estimate the following fixed effects model:
 ln ys,t = β0 + βu unfilleds,t + βd D
date
t + βhhs,t + νs
GP + εs,tGP  
 (3)
The notations and the explanatory variables are essen-
tially the same as in equation (1). Since the data are on 
the annual level, the time dummies are year dummies 
now. The dependent variables (lnys,t) are the logarithm of 
the per capita annual number of GP visits and the loga-
rithm of the ratio of antibiotic prescriptions to GP visits.
Patient and public involvement
No patients were involved in the research, as it was based 
on the retrospective analysis of administrative data.
reSultS
Descriptive analysis
Unfilled general practices
The number and the share of unfilled general practices 
increased from 150 (2.3%) in 2008 to 350 (5.5%) in 
2016. Based on the (censored) data covering years 2004 
to 2017, the observed mean duration of a practice being 
unfilled is 4.9 years, the median is 3.3 years.
Figure 1 shows the spatial distribution of settlements 
with unfilled general practices as of December 2015. 
While unfilled practices are scattered all over Hungary, 
their distribution is more dense in the Eastern part of 
the country, especially in the poorer North-Eastern part. 
Between years 2010 to 2015 (in the period on which our 
main antibiotic analysis is based), about two-third of 
unfilled general practices were in villages, and the share 
of unfilled practices increased from 5.8% to the substan-
tial 10.9% in this settlement category. As the analysis 
presented in online supplementary appendix A2 shows, 
unfilled general practices are on average more common 
in the less affluent villages, for example, where the unem-
ployment rate is higher.
Within villages over years 2010 to 2015, the annual per 
capita number of GP visits was 8.0.
Consumption of antibiotics
Based on the NHIFA data, throughout years 2010 to 2015, 
the average per capita annual expenditures on antibiotics 
(social security plus out-of-pocket payments) were 4.5 
EUR (1350 HUF), which accounted for 3.0% of the total 
per capita expenditures on prescribed pharmaceuticals 
(148 EUR (44 300 HUF)). Thirty per cent of antibiotic 
expenditures were paid by the social security. The DOT of 
antibiotics was 14.2 per 1000 inhabitant-days throughout 
years 2010 to 2015, without major time trend (15.1 in 
2010, 14.8 in 2015).
Antibiotic consumption is strongly seasonal: compared 
with the summer months, expenditures more than 
double in the winter (online supplementary figure A3 in 
appendix A3). According to table 1, antibiotic DOT per 
1000 inhabitant-days is higher for women than for men 
(by 23%), and higher for children than for adults, but the 
age differences are more pronounced for men than for 
women. Gender differences are partly due to the common 
use of antibiotics for the treatment of urinary tract infec-
tions among women. There is a non-negligible variation 
in per capita antibiotic consumption across counties in 
Hungary. In line with Matuz et al,10 the use of antibiotics 
tends to be higher in the poorer areas (Eastern, North-
Eastern and Southern Hungary – online supplementary 
figure A4 in appendix A3).
effects on the quantity of antibiotic consumption
The estimation results of equation (1) are reported 
in table 2. The fixed effects logarithmic models show 
that when the single general practice covering a village 
becomes unfilled, then antibiotic DOT decreases by 0.033 
on the logarithmic scale, that is, by 3.2% (95% CI 1.0% to 
5.4%) and antibiotic expenditures by 0.026 on the loga-
rithmic scale, that is, by 2.5% (95% CI 0.3% to 4.7%). 
(If γ is an effect parameter in the logarithmic model 
then 100·(exp(γ)−1) is the percentage effect on the orig-
inal scale, which is roughly 100·γ if γ is close to zero). In 
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absolute terms, the reducing effect is 0.6 DOT per 1000 
inhabitant-days if the ratio of unfilled practices increases 
from zero to one.
Table 2 also shows that the random effects models yield 
almost identical estimates for the impact of the unfilled 
practices, so the above results are robust to this spec-
ification change. Meanwhile, the parameters of some 
control variables differ substantially across the fixed/
random effects specifications. As a consequence, the 
Hausman-type overidentification test rejects the random 
effects model in favour of the fixed effects specification 
even at the 0.1% significance level for all three depen-
dent variables. In the following we will display the fixed 
effects results.
Further specification checks were also performed. The 
estimation results change only slightly if the main explan-
atory variable – the continuous indicator of the ratio of 
unfilled practices – is replaced with a categorical variable 
that takes three distinct values: it equals 0 if the ratio of 
unfilled practices is 0, equals 1 if the ratio of unfilled 
practices is between 0 and 1 and equals 2 if the ratio of 
unfilled practices is 1. In other words, here we distinguish 
the settlements where no practices are unfilled, where all 
practices are unfilled and where some practices are filled 
and some are unfilled (middle category). Additionally, to 
check for non-linearities, we include the squared terms of 
all control variables in the model.
According to the parameter estimates in this specifica-
tion, if all GP practices (typically the single available GP 
practice) become unfilled, that implies a 3.7% lower per 
capita antibiotic DOT (95% CI: 1.5% to 5.8%) compared 
with the ‘none unfilled’ category, which is very close to the 
estimate of the linear specification presented in table 2 
(ie, 3.2%). Meanwhile, if there are more than one GP 
practices and some but not all of them become unfilled, 
that has no significant effect on antibiotic consumption 
(effect size is −0.5%, 95% CI −2.5% to +1.4%).
Finally, specification checks (not shown here in detail) 
reveal that above the contemporaneous effect, past and 
future (ie, previous and next year’s) unfilled status of the 
general practice have no significant effect on antibiotic 
use. Thus, we find no evidence for adjustment in anti-
biotic use after the immediate negative effect of a prac-
tice becoming unfilled. We also do not see evidence that 
people would adjust their antibiotic use in anticipation of 
a practice becoming unfilled.
Heterogeneity analyses
The heterogeneity analyses are reported in table 3. 
According to the first column, a poorer supply of health-
care services (as captured by the availability of specialist 
care and pharmacies) strengthens the negative effect of 
unfilled general practices on antibiotic consumption. 
Lower supply of specialist care implies less opportunity 
for substitution of primary care, leading to the stronger 
effect of the availability of primary care on antibiotic use. 
Meanwhile, there is no effect heterogeneity according to 
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Table 3 Heterogeneous effect of the ratio of unfilled general practices
Dependent variable: log of per capita DOT
(1): Heterogeneity by settlement 
characteristics
(2): Heterogeneity by baseline 
antibiotic use
Ratio of unfilled practices (RUGP) −0.0746*** (0.0231) −0.0304** (0.0151)
RUGP ×pharmacy present in settlement 0.0611*** (0.0185)   
RUGP ×specialist outpatient hours in 
micro-region/1000 inhabitants
0.0147* (0.00815)   
RUGP ×unemployment rate in settlement −0.0688 (0.112)   
RUGP ×prescription exemption rate in 
settlement
−0.187 (0.239)   
RUGP ×residual of antibiotic use in 2010   −0.112* (0.0588)
Ratio of females 1.454*** (0.189) 1.173** (0.460)
Age 0–17 ratio −0.229 (0.266) −0.383 (0.505)
Age 60 plus ratio −0.0844 (0.246) −0.0123 (0.455)
Unemployment rate −0.130** (0.0645) −0.143 (0.0896)
Prescription exemption rate 0.247** (0.122) 0.239 (0.219)
Specialist outpatient capacities −0.00214 (0.00509) −0.0102 (0.0290)
Monthly date effects yes yes
Settlement fixed effects yes yes
Cluster-robust SEs in brackets with clustering on the micro-regional level, *p<0.1, **p<0.05, ***p<0.01. Settlement-month level NHSC data, 
weighted by the population of settlements,years: 2010 to 2015 in model (1), 2013 to 2015 in model (2). Number of observations: 162 311 in 
model (1), 79.432 in model (2) (number of settlements: 2316).
DOT, days of therapy; NHSC, National Healthcare Services Centre; RUGP, ratio of unfilled general practices.
socioeconomic conditions measured by the local unem-
ployment rate and the prescription exemption rate.
The results reported in the second column of table 3 
suggest that a major fraction of the negative effect of 
unfilled general practices originates from settlements 
where the baseline use of antibiotics was comparatively 
high. In settlements where the initial use of antibiotics 
was higher by one standard deviation (by 0.35 on loga-
rithmic scale), the negative effect on the logarithm of 
antibiotic consumption is stronger by 0.039, comparable 
with the magnitude of the average effect.
effects on quality indicators
We investigate some further indicators of antibiotic use 
that can provide evidence whether the quality of anti-
biotic prescriptions is affected by the unfilled status of 
general practices.
First, we look at the effect of the ratio of unfilled general 
practices on the use of narrow-spectrum versus broad-spec-
trum antibiotics. According to fixed effects panel regres-
sions (table 4), this quality index decreases substantially by 
0.023 (from an average level of 0.18) if a practice becomes 
unfilled, suggesting quality deterioration. The numerator 
(consumption of narrow-spectrum antibiotics) decreases 
by 7.5% (ie, by 0.078 on the logarithmic scale), while the 
denominator (consumption of broad-spectrum antibiotics) 
decreases by a statistically insignificant 1.4%.
Second, table 4 also shows that the consumption of 
Access antibiotics decreases statistically significantly by 3.1% 
(ie, by 0.032 on the logarithmic scale) if a practice becomes 
unfilled, while the consumption of Watch and Reserve anti-
biotics decreases by a statistically insignificant 1.9%. These 
results again suggest a quality worsening effect.
GP care use and antibiotics: understanding the mechanism
We also examine how the effect of unfilled general prac-
tices on the number of GP visits interferes with the effect 
on antibiotic use. Our regression results show that living 
in a village where the single general practice is unfilled 
implies on average 9.3% fewer GP visits (95% CI 5.6% to 
12.9%; −0.098 on the logarithmic scale), holding settle-
ment-level controls and time invariant characteristics 
fixed, and netting out time effects (table 5, first column). 
Due to the measurement error in the GP care use indicator 
(measured at the centre of a catchment area, as explained 
in section Settlement-level demographic, socio-economic 
and GP care data), the true effect could be even higher. 
Nevertheless, the results indicate a substantial negative 
effect of unfilled practices on GP care use.
It is also known from our results that per capita antibi-
otic DOT decreases on average only by 3.2% (table 2). 
The smaller decrease in antibiotic use than in GP visits 
suggests that the limited availability of GP care is partly 
compensated by a higher likelihood of antibiotic prescrip-
tion per GP visit. Indeed, as shown in the second column 
of table 5, a general practice becoming unfilled increases 
antibiotic prescriptions per GP visits by 7.5% (ie, by 0.073 
on the logarithmic scale). Hence the overall negative 
effect of unfilled practices on antibiotic use stems from 
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Table 4 Effect of the ratio of unfilled general practices on the use of selected antibiotic categories
 
 
Log of per capita DOT
Quality index Broad spectrum Narrow spectrum Access Watch & Reserve
Ratio of unfilled 
practices
−0.0233** (0.0101) −0.0139 (0.0129) −0.0781** (0.0387) −0.0319** 
(0.0137)
−0.0187 (0.0176)
Ratio of females −0.134 (0.122) 1.625*** (0.212) 1.500*** (0.519) 1.466*** (0.246) 1.376*** (0.290)
Age 0–17 ratio 0.154 (0.1860) −0.373 (0.279) −1.087 (0.766) −0.0951 (0.329) −0.411 (0.404)
Age 60 plus ratio 0.257* (0.154) −0.268 (0.273) 0.0341 (0.704) −0.162 (0.302) −0.101 (0.369)
Unemployment 
rate
−0.0393 (0.0423) −0.0904 (0.0637) −0.591*** (0.194) −0.224** (0.0934) −0.0415 (0.0788)
Prescription 
exemption rate
−0.0371 (0.0819) 0.209* (0.109) 0.276 (0.407) 0.230 (0.153) 0.407*** (0.150)
Specialist 
outpatient 
capacities
−0.00293 (0.00381) −0.00119 (0.00463) 0.00252 (0.0211) 0.00290 (0.00795) −0.00168 (0.00864)
Monthly date 
effects
yes yes yes yes yes
Settlement fixed 
effects
yes yes yes yes yes
Observations 162 256 162 256 141 208 161 866 161 261
Cluster-robust SEs in brackets with clustering on the micro-regional level, *p<0.1, **p<0.05, ***p<0.01. Settlement-month level NHSC data, 
weighted by the population of settlements, years: 2010 to 2015. Number of settlements: 2316. Quality index: ratio of DOT of narrow-spectrum 
vs broad-spectrum antibiotics.
DOT, days of therapy; NHSC, National Healthcare Services Centre.
Table 5 Effect of the ratio of unfilled general practices on annual GP visits and antibiotics prescription per GP visit
Log of annual GP visits per capita Log of antibiotic DOT per GP visit
Ratio of unfilled practices −0.0980*** (0.0207) 0.0726*** (0.0230)
Ratio of females 1.440*** (0.333) −0.252 (0.388)
Age 0–17 ratio −1.126*** (0.371) 1.042** (0.437)
Age 60 plus ratio 0.592 (90.392) −0.632 (0.475)
Unemployment rate −0.0202 (0.0847) −0.117 (0.0999)
Prescription exemption rate 0.498*** (0.180) −0.339* (0.195)
Specialist outpatient capacities −0.00425 (0.00596) 0.000564 (0.00585)
Year effects yes Yes
GP catchment area fixed effects yes Yes
Cluster-robust SEs in brackets with clustering on the micro-regional level, *p<0.1, **p<0.05, ***p<0.01. GP catchment area-year level T-STAR 
data, weighted by the population of GP catchment areas, years: 2010 to 2015. Number of observations: 8505 (number of GP catchment 
areas: 1438).
DOT, days of therapy; GP, general practitioner.
the limited access to GP care, and not from the deputy 
GPs prescribing fewer antibiotics per visit.
DISCuSSIOn
Using administrative data from Hungary, we estimated 
the effect of primary care availability on antibiotic use. 
We exploited the geographical and time variation in 
unfilled general practices as a source of exogenous vari-
ation in primary care supply. We estimated a negative 
3.2% average effect on per capita antibiotic use if the 
ratio of unfilled general practices increase from 0 to 1 
in a settlement (eg, if the only general practice becomes 
unfilled in a settlement). Larger effects are observed 
for settlements with limited availability of specialist care 
and pharmacies. While the use of antibiotics decreases 
as a consequence of the supply-side effects, we also find 
evidence that the quality of antibiotic prescriptions 
deteriorates.
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In our main specification, we estimated panel regres-
sions with settlement-level fixed effects. This strengthens 
the identification of the parameters of our interest because 
we could control for any time-invariant unmeasured char-
acteristics of the settlements that could interfere with the 
probability of a general practice being unfilled. We also 
demonstrated that the use of settlement-level random 
effects, or a non-linear specification in the explanatory 
variables give almost identical estimates for the impact of 
unfilled practices on antibiotic indicators, so our results 
are robust to these specification changes.
Our results come from a healthcare system where 
general practices are overwhelmingly single-handed and 
group practices are extremely rare. Therefore, our main 
explanatory variable, the ratio of unfilled practices in a 
village, captures the availability of primary care reasonably 
well. We note, however, that using a more conventional 
indicator such as the number of GPs per 1000 inhabitants 
gives similar results: higher density of GPs is associated 
with higher use of antibiotics. Specifically, if the number 
of available GPs per 1000 inhabitants in a settlement 
increases by one (the average of this measure is 1.7 in our 
sample) then per capita antibiotic use increases by 2.2% 
(95% CI 1.3% to 3.2%), according to our calculations.
Our results are in line with the literature showing 
that geographical distance to healthcare facilities nega-
tively affects healthcare use (Haynes et al, Hyndman et al, 
Elek et al30–32, among others). Also, we contribute to the 
literature on the determinants of antibiotic prescribing 
behaviour of GPs. There is evidence that pay-for-perfor-
mance programmes can reduce broad-spectrum antibi-
otic prescribing.33 34 Our results indicate that reduced 
availability of primary care worsens the quality of antibi-
otic prescribing; the share of broad-spectrum antibiotics 
increases.
The study is subject to some limitations. The external 
validity is restricted to similar healthcare systems, that is 
to systems with mostly single-handed general practices, 
which serve as the first point of contact to the system. 
Also, while the consumption of pharmaceuticals other 
than antibiotics is also likely to be affected by the avail-
ability of primary care, it remains for future research to 
investigate these effects. Finally, despite the richness of 
the administrative data used, we face some data limita-
tions. There could still remain unobserved time-varying 
confounders that are related both to antibiotic use and 
the availability of GP care (such as changing population 
health status and health behaviour). We do not have infor-
mation on who exactly – among the other GPs – provide 
service as deputy GP and how exactly the opening hours 
change if a general practice becomes unfilled. Also, we do 
not know to what extent patients switch from an unfilled 
general practice to another, filled one. These details 
could provide further insights into the mechanisms how 
primary care availability affects antibiotic use.
Overall, the results suggest that given the socioeco-
nomic status of a settlement, and given the supply of 
secondary care, the availability of primary care has a 
non-negligible effect on the quantity and quality of anti-
biotic consumption. The main message is that antibiotic 
use can be influenced by supply-side factors, the usage 
is sensitive to the access to primary care. The overuse of 
antibiotics might be limited if the number of avoidable 
visits to primary care physicians is decreased. However, it 
is important to keep in mind that for avoiding antibiotic 
resistance, it is desirable not only to reduce the overall 
use of antibiotics, but also to shift consumption towards 
narrow-spectrum antibiotics. According to our results, 
such a quality improvement cannot be achieved with 
limiting the availability of primary care.
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